Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07147647 · ClinicalTrials.gov registry record · NA
Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
A NA study of Primary Open Angle Glaucoma (POAG), sponsored by Select Eye Care.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07147647: Recruiting NA study of Primary Open Angle Glaucoma (POAG), sponsored by Select Eye Care.
NCT07147647 is a NA study of Primary Open Angle Glaucoma (POAG) that is actively recruiting participants, run by Select Eye Care. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07147647, a NA study of Primary Open Angle Glaucoma (POAG), is actively recruiting participants, sponsored by Select Eye Care.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.
Conditions Studied
Interventions
- DEVICE Direct Selective Laser Trabeculoplasty
Study Locations (1)
Maryland
- Select Eye Care - Elkridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-07-16 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT07147647 shows while recruiting
NCT07147647 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Primary Open Angle Glaucoma (POAG) appearing as the primary indexed condition, and to 1 intervention - of which Direct Selective Laser Trabeculoplasty is the first listed.
NCT07147647 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT07147647 about?
NCT07147647 is a clinical study titled "Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma". The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when ...
What is the current status of trial NCT07147647?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-16. Estimated completion is 2026-10.
What conditions does trial NCT07147647 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma (POAG).
What interventions are being tested in trial NCT07147647?
The interventions under investigation include: Direct Selective Laser Trabeculoplasty (DEVICE).
Who is sponsoring clinical trial NCT07147647?
This trial is sponsored by Select Eye Care, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07147647 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma (POAG)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07147647's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI